Table 1.
Patient participant characteristics
| Variable | Count (%) |
| Age | |
| <40 | 2/22 (9) |
| 40–49 | 3/22 (13) |
| 50–59 | 5/22 (23) |
| 60–69 | 3/22 (14) |
| 70–79 | 6/22 (27) |
| >80 | 3/22 (13) |
| Gender | |
| Male | 12/22 (55) |
| Female | 10/22 (45) |
| Ethnicity | |
| White British |
16/22 (73) |
| Black British |
4/22 (18) |
| Asian/Asian British |
2/22 (9) |
| In-centre dialysis |
15/22 (68) |
| Morning sessions | 12/15 (80) |
| Home HD | 7/22 (32) |
| Current vascular access | |
| Arteriovenous fistula | 19/22 (86) |
| Arteriovenous graft | 0/22 (0) |
| Central venous catheter | 3/22 (14) |
| Charlson Comorbidity Score | |
| <2 | 1 (4) |
| 3–4 | 5 (23) |
| 5–6 | 4 (18) |
| 7–8 | 6 (27) |
| 9–10 | 5 (23) |
| 11–12 | 1 (4) |
| 13+ | 0 (0) |
| Time since dialysis commencement (years) | |
| ≤5 | 11/22 (50) |
| 6–10 | 5/22 (23) |
| 11–15 | 3/22 (14) |
| 16–20 | 1/22 (4.5) |
| >20 | 2/22 (9) |
Charlson Comorbidity Index (CCI)65 quantifies an individual’s burden of disease and corresponding 1-year mortality risk. The index adjusts for 17 comorbidities, each one classified with a validated score of 1–6 points, based on the adjusted relative risk of 1‐year mortality. The final total score is used to calculate the probability of survival. The index is being used in this context to demonstrate the overall disease burden of the population under study.
n=22.
HD, haemodialysis.